piracetam has been researched along with Myasthenia Gravis in 1 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
Myasthenia Gravis: A disorder of neuromuscular transmission characterized by fatigable weakness of cranial and skeletal muscles with elevated titers of ACETYLCHOLINE RECEPTORS or muscle-specific receptor tyrosine kinase (MuSK) autoantibodies. Clinical manifestations may include ocular muscle weakness (fluctuating, asymmetric, external ophthalmoplegia; diplopia; ptosis; and weakness of eye closure) and extraocular fatigable weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles (ocular myasthenia). THYMOMA is commonly associated with this condition.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aysal, F | 1 |
| Baybas, S | 1 |
| Selçuk, HH | 1 |
| Sozmen, V | 1 |
| Ozturk, M | 1 |
| Kucukoglu, H | 1 |
| Urer, NH | 1 |
1 other study available for piracetam and Myasthenia Gravis
| Article | Year |
|---|---|
Paraneoplastic extralimbic encephalitis associated with thymoma and myastenia gravis: three years follow up.
Topics: Anticonvulsants; Cholinesterase Inhibitors; Electroencephalography; Follow-Up Studies; Levetiracetam | 2013 |